• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Acorda Therapeutics

Acorda Therapeutics

  1. Acorda Therapeutics' stock plummets toward biggest-ever loss amid disappointing patent ruling

    Acorda Therapeutics' stock plummets toward biggest-ever loss amid disappointing patent ruling

  2. Acorda Announces Long-Term Safety Data for CVT-301

    Acorda Announces Long-Term Safety Data for CVT-301

©2017 Morningstar Advisor. All right reserved.